Incyte Gears Up to Report Q3 Earnings: Here's What You Should Know

Incyte Corporation (INCY) is scheduled to report third-quarter 2024 results on Oct. 29, before the opening bell.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Shares of Incyte have risen 3.9% in the year-to-date period against the industry’s decline of 1.8%.Image Source: Zacks Investment ResearchLet’s see how things might have shaped up prior to the announcement.Factors to NoteIncyte primarily derives product revenues from the sales of its lead drug, Jakafi (ruxolitinib), in the Un ...